Benjamin Halladay - Net Worth and Insider Trading
Benjamin Halladay Net Worth
The estimated net worth of Benjamin Halladay is at least $563,217 dollars as of 2025-01-12. Benjamin Halladay is the CFO of Esperion Therapeutics Inc and owns about 240,691 shares of Esperion Therapeutics Inc (ESPR) stock worth over $563,217. Details can be seen in Benjamin Halladay's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Benjamin Halladay has not made any transactions after 2024-12-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Benjamin Halladay
Benjamin Halladay Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Benjamin Halladay owns 1 companies in total, including Esperion Therapeutics Inc (ESPR) .
Click here to see the complete history of Benjamin Halladay’s form 4 insider trades.
Insider Ownership Summary of Benjamin Halladay
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2024-12-17 | Chief Financial Officer |
Benjamin Halladay Latest Holdings Summary
Benjamin Halladay currently owns a total of 1 stock. Benjamin Halladay owns 240,691 shares of Esperion Therapeutics Inc (ESPR) as of December 17, 2024, with a value of $563,217.
Latest Holdings of Benjamin Halladay
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2024-12-17 | 240,691 | 2.34 | 563,217 |
Holding Weightings of Benjamin Halladay
Benjamin Halladay Form 4 Trading Tracker
According to the SEC Form 4 filings, Benjamin Halladay has made a total of 1 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Esperion Therapeutics Inc is the sale of 3,245 shares on December 17, 2024, which brought Benjamin Halladay around $7,853.
Insider Trading History of Benjamin Halladay
- 1
Benjamin Halladay Trading Performance
Benjamin Halladay Ownership Network
Ownership Network List of Benjamin Halladay
Ownership Network Relation of Benjamin Halladay
Benjamin Halladay Owned Company Details
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Benjamin Halladay is the Chief Financial Officer of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Operating Officer Sheldon L. Koenig , Chief Commercial Officer Eric Warren , and Chief Medical Officer Joanne M. Foody .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Benjamin Halladay made 1 insider transaction in Esperion Therapeutics Inc (ESPR) with a net sale of 3,245. Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 9,288 shares made by Eric Warren , a net sale of 26,997 shares made by Sheldon L. Koenig , and a net sale of 4,202 shares made by Joanne M. Foody .
In summary, during the past 3 months, insiders sold 18,230 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 18,230 shares. During the past 18 months, 43,732 shares of Esperion Therapeutics Inc (ESPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 43,732 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
Benjamin Halladay Mailing Address
Above is the net worth, insider trading, and ownership report for Benjamin Halladay. You might contact Benjamin Halladay via mailing address: Esperion Therapeutics, Inc., 3891 Ranchero Drive, Suite 150, Ann Arbor Mi 48108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
